Journals / Experimental Biomedical Research / 2020 / Cilt: 3 - Sayı: 4

A comprehensive review on rational and effective treatment strategies against an invisible enemy; SARS Cov-2 infection

Pages
293–311
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, mainstay of the SARS Cov-2 treatment is general measures such as patient isolation and supportive care.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The year 2020 is began with the declaration of a pandemic of novel coronavirus, which first occurred by the end of 2019 in Wuhan region of China.
📊
Key Findings & Data:The novel virus infection is so called as Covid-19 or SARS Cov-2.
💡
Conclusion & Impact:In conclusion, mainstay of the SARS Cov-2 treatment is general measures such as patient isolation and supportive care.
🔬Design:Review & Systematic Survey
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Özet

The year 2020 is began with the declaration of a pandemic of novel coronavirus, which first occurred by the end of 2019 in Wuhan region of China. The novel virus infection is so called as Covid-19 or SARS Cov-2. The infection rapidly spread all over the world and changed the lives of millions. In this extended review, we aimed to discuss current and possible treatment strategies against SARS Cov-2 infection. Treatment options mentioned here include but not limited to chloroquine/hydroxychloroquine, favipiravir, remdesivir, lopinavir/ritonavir, umifenovir, steroids, cepharanthine, convalescent plasma, anticoagulants and monoclonal antibodies. In conclusion, mainstay of the SARS Cov-2 treatment is general measures such as patient isolation and supportive care. However, encouraging developments are being achieved in terms of discovery of an effective treatment and production of a potent vaccine.

🔖

Cite This Article

AKTAŞ, G. (2020). A comprehensive review on rational and effective treatment strategies against an invisible enemy; SARS Cov-2 infection. Experimental Biomedical Research, Cilt: 3 - Sayı: 4, 293–311. https://ajindex.com/articles/158711

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Cortegiani A, Ingoglia G, Ippolito M et al. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID- 19. J Crit Care. 2020;57:279-83
  2. Hoffmann M, Kleine-Weber H, Schroeder S et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271-80
  3. Zhao Y, Zhao Z, Wang Y et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. BioRxiv. 2020: doi: 10.1101/2020.01.26.919985
  4. Tikellis C, Thomas MC. Angiotensin- Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease. Int J Pept. 2012;2012:256294
  5. Zhang H, Penninger JM, Li Y et al. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586-90
  6. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020: doi: 10.1001/jama.2020.2648
  7. Lavezzo E, Franchin E, Ciavarella C et al. Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'. Nature. 2020;584(7821):425-29
  8. Chen N, Zhou M, Dong X et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395 (10223):507-13
  9. Yang X, Yu Y, Xu J et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-81
  10. Pascarella G, Strumia A, Piliego C et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020;288(2):192-206
  11. Jiang F, Deng L, Zhang L et al. Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19). J Gen Intern Med. 2020;35(5):1545-49
  12. World Health Organisation. Coronavirus Disease (COVID-19) Dashboard. In: WHO; 2020. https://covid19.who.int/?gclid=EAIaIQobC hMI3YCC-- u26wIVWuztCh1JzAh8EAAYASABEgLIh vD_BwE
  13. Bilgin S, Kurtkulagi O, Kahveci GB et al. Millennium pandemic: a review of coronavirus disease (COVID-19). Exp Biomed Res. 2020;3(2):117-25
  14. Li T. Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation o